- The 8 States Most Likely to Legalize Marijuana Next
- BlackBerry Is Finally Realizing Smartphones Aren't the Answer
- Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market
- Dow 18,000: Why This Market Rally May Never Happen Again
- Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer
Top of the list: The retailer must find its niche.
There are not many opportunities left for the wise and rational value investors. Here are two undervalued needles in this market haystack.
SiriusXM suffers the same disease as the federal government -- takes its revenue stream for granted and spends wildly.
A prime opportunity to take a bearish position in a company that is ridiculously overvalued.